Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;20(3):387-396.
doi: 10.1002/wps.20906.

Initial treatment choices to achieve sustained response in major depression: a systematic review and network meta-analysis

Affiliations

Initial treatment choices to achieve sustained response in major depression: a systematic review and network meta-analysis

Toshi A Furukawa et al. World Psychiatry. 2021 Oct.

Abstract

Major depression is often a relapsing disorder. It is therefore important to start its treatment with therapies that maximize the chance of not only getting the patients well but also keeping them well. We examined the associations between initial treatments and sustained response by conducting a network meta-analysis of randomized controlled trials (RCTs) in which adult patients with major depression were randomized to acute treatment with a psychotherapy (PSY), a protocolized antidepressant pharmacotherapy (PHA), their combination (COM), standard treatment in primary or secondary care (STD), or pill placebo, and were then followed up through a maintenance phase. By design, acute phase treatment could be continued into the maintenance phase, switched to another treatment or followed by discretionary treatment. We included 81 RCTs, with 13,722 participants. Sustained response was defined as responding to the acute treatment and subsequently having no depressive relapse through the maintenance phase (mean duration: 42.2±16.2 weeks, range 24-104 weeks). We extracted the data reported at the time point closest to 12 months. COM resulted in more sustained response than PHA, both when these treatments were continued into the maintenance phase (OR=2.52, 95% CI: 1.66-3.85) and when they were followed by discretionary treatment (OR=1.80, 95% CI: 1.21-2.67). The same applied to COM in comparison with STD (OR=2.90, 95% CI: 1.68-5.01 when COM was continued into the maintenance phase; OR=1.97, 95% CI: 1.51-2.58 when COM was followed by discretionary treatment). PSY also kept the patients well more often than PHA, both when these treatments were continued into the maintenance phase (OR=1.53, 95% CI: 1.00-2.35) and when they were followed by discretionary treatment (OR=1.66, 95% CI: 1.13-2.44). The same applied to PSY compared with STD (OR=1.76, 95% CI: 0.97-3.21 when PSY was continued into the maintenance phase; OR=1.83, 95% CI: 1.20-2.78 when PSY was followed by discretionary treatment). Given the average sustained response rate of 29% on STD, the advantages of PSY or COM over PHA or STD translated into risk differences ranging from 12 to 16 percentage points. We conclude that PSY and COM have more enduring effects than PHA. Clinical guidelines on the initial treatment choice for depression may need to be updated accordingly.

Keywords: Major depression; cognitive behavioral therapy; combination therapy; maintenance treatment; network meta-analysis; pharmacotherapy; psychotherapy; sustained response; treatment choice.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Trial designs to examine maintenance treatment for depression. MDE – major depressive episode, COM – combination therapies, PHA – pharmacotherapies, PSY – psychotherapies, nat – discretionary treatment, R – randomization
Figure 2
Figure 2
PRISMA flow chart. MDD – major depressive disorder, CBT – cognitive behavioral therapy
Figure 3
Figure 3
Network diagram for sustained response. COM – combination therapies, PHA – pharmacotherapies, PSY – psychotherapies, STD – standard treatment in primary or secondary care, nat – discretionary treatment. The size of the node is proportionate to the number of participants allocated to that node; the width of the line is proportionate to the number of studies examining that comparison.
Figure 4
Figure 4
Ranked forest plot for sustained response. NMA – network meta‐analysis, OR – odds ratio, CI – confidence interval, COM – combination therapies, PHA – pharmacotherapies, PSY – psychotherapies, STD – standard treatment in primary or secondary care, nat – discretionary treatment
Figure 5
Figure 5
Ranked forest plot for all‐cause discontinuation. NMA – network meta‐analysis, OR – odds ratio, CI – confidence interval, COM – combination therapies, PHA – pharmacotherapies, PSY – psychotherapies, STD – standard treatment in primary or secondary care, nat – discretionary treatment
Figure 6
Figure 6
Ranked forest plot for sustained response with intervention subtypes. NMA – network meta‐analysis, OR – odds ratio, CI – confidence interval, STD – standard treatment in primary or secondary care, DYN – psychodynamic therapy, AD – protocolized antidepressant pharmacotherapy, MI – motivational interviewing, TAU – treatment as usual, nat – discretionary treatment, SST – social skills training, CBT – cognitive behavioral therapy, IPT – interpersonal therapy, Family – family therapy, BA – behavioral activation therapy, SUP – non‐directive supportive therapy, LRT – life review therapy, PST – problem‐solving therapy, 3W – third‐wave cognitive behavioral therapy, NT – no treatment, pl – pill placebo

Comment in

References

    1. Cipriani A, Furukawa TA, Salanti G et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta‐analysis. Lancet 2018;391:1357‐66. - PMC - PubMed
    1. Cuijpers P, Quero S, Noma H et al. Psychotherapies for depression: a network meta‐analysis covering efficacy, acceptability and long‐term outcomes of all main treatment types. World Psychiatry 2021;20:283‐93. - PMC - PubMed
    1. Geddes JR, Carney SM, Davies C et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003;361:653‐61. - PubMed
    1. Sim K, Lau WK, Sim J et al. Prevention of relapse and recurrence in adults with major depressive disorder: systematic review and meta‐analyses of controlled trials. Int J Neuropsychopharmacol 2015;19:pyv076. - PMC - PubMed
    1. Cuijpers P, Hollon SD, van Straten A et al. Does cognitive behaviour therapy have an enduring effect that is superior to keeping patients on continuation pharmacotherapy? A meta‐analysis. BMJ Open 2013;3:e002542. - PMC - PubMed